Close Menu

NEW YORK (GenomeWeb) – NeoGenomics today reported a 25 percent year-over-year jump in its Q4 revenues, buoyed by its recently completed acquisition of Genoptix.

The cancer genetic testing company reported revenues of $76.5 million for the three-month period ended Dec. 31, 2018, up from restated revenues of $61.4 million in the same period last year. The consensus Wall Street estimate was $71.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.